Altimmune (ALT) Amortizatization of Intangibles (2016 - 2026)
Altimmune (ALT) reported Amortizatization of Intangibles of $870000.0 for Q1 2026, up 26.82% year-over-year from $686000.0 in Q1 2025, and down 4.5% on a QoQ basis from $911000.0 in Q4 2025.
Altimmune (ALT) has 9 years of Amortizatization of Intangibles data on file, last reported at $870000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 26.82% year-over-year to $870000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 32.23% YoY) and the FY2025 annual result came in at $2.2 million, down 42.23% from the prior year.
- Amortizatization of Intangibles retreated to $870000.0 in Q1 2026 per ALT's latest filing, from $911000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q2 2024 and bottomed at $196000.0 in Q3 2025.
- The 4-year median for Amortizatization of Intangibles is $695000.0 (2023), against an average of $724230.8.
- The widest annual swing landed in 2024, when Amortizatization of Intangibles surged 104.37%; it then slumped 79.98% in 2025.
- Tracing ALT's Amortizatization of Intangibles over 4 years: stood at $695000.0 in 2023, then rose by 17.84% to $819000.0 in 2024, then gained by 11.23% to $911000.0 in 2025, then slipped by 4.5% to $870000.0 in 2026.
- Per Business Quant, the three latest ALT Amortizatization of Intangibles figures stand at $870000.0 (Q1 2026), $911000.0 (Q4 2025), and $196000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | 870,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 870,000.00 |
| Mar 31, 2026 | 870,000.00 |
| Dec 31, 2025 | 911,000.00 |
| Dec 31, 2025 | 911,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 983,000.00 |
| Mar 31, 2024 | 983,000.00 |
| Dec 31, 2023 | 695,000.00 |
| Dec 31, 2023 | 695,000.00 |
| Sep 30, 2023 | 669,000.00 |
| Sep 30, 2023 | 669,000.00 |
| Jun 30, 2023 | 626,000.00 |
| Jun 30, 2023 | 626,000.00 |
| Mar 31, 2023 | 481,000.00 |
| Mar 31, 2023 | 481,000.00 |
| Sep 30, 2020 | 10,406.00 |
| Sep 30, 2020 | 10,406.00 |
| Jun 30, 2020 | 12,025.00 |
| Jun 30, 2020 | 12,025.00 |
| Mar 31, 2020 | 13,851.00 |
| Mar 31, 2020 | 13,851.00 |
| Dec 31, 2019 | 11,836.00 |
| Dec 31, 2019 | 11,836.00 |
| Sep 30, 2019 | 28,084.00 |
| Sep 30, 2019 | 28,084.00 |
| Jun 30, 2019 | 14,836.00 |
| Jun 30, 2019 | 14,836.00 |
| Mar 31, 2019 | 92,744.00 |
| Mar 31, 2019 | 92,744.00 |
| Dec 31, 2018 | 38,226.00 |
| Dec 31, 2018 | 38,226.00 |
| Sep 30, 2018 | 15,980.00 |
| Sep 30, 2018 | 15,980.00 |
| Jun 30, 2018 | 14,818.00 |
| Jun 30, 2018 | 14,818.00 |
| Mar 31, 2018 | 14,628.00 |
| Mar 31, 2018 | 14,628.00 |
| Dec 31, 2017 | 14,776.00 |
| Dec 31, 2017 | 14,776.00 |
| Sep 30, 2017 | 14,257.00 |
| Sep 30, 2017 | 14,257.00 |
| Jun 30, 2017 | 13,597.00 |
| Jun 30, 2017 | 13,597.00 |
| Mar 31, 2017 | 12,555.00 |
| Mar 31, 2017 | 12,555.00 |
| Dec 31, 2016 | 11,684.00 |
| Dec 31, 2016 | 11,684.00 |
| Sep 30, 2016 | 11,764.00 |
| Sep 30, 2016 | 11,764.00 |